NCT00263237View on ClinicalTrials.gov

STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 2, 2005

Study Completion Date

July 23, 2008

Conditions
Common Variable Immunodeficiency
Interventions
DRUG

STA-5326

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00263237 - STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency | Biotech Hunter | Biotech Hunter